Eyeworld – APR 2022
EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.
Related Articles
EyeWorld Weekly, May 3, 2024 – EyeWorld
➤ FDA clears fully autonomous, portable AI device for diabetic retinopathy screening ➤ Positive preliminary data for Phase 1/2 trial evaluating gene therapy treatment for…
Being organized can boost your practice – EyeWorld
Being organized and understanding every component of a practice is not merely helpful, it is essential. This Practice Management column provided a checklist of what…
50 Years | 50 States | 50 Perspectives
In honor of the 50th anniversary of ASCRS, member ophthalmologists from the 50 states are sending in their perspectives on the Society, its impact on…
Current perspectives on NTG and progression at low IOPs – EyeWorld
Two physicians provided their thoughts on diagnosis of normal tension glaucoma, establishing true progression, and how to manage worsening disease in this patient population
Should I join a Private Equity after training?
Presenters: Sanja Cypen, MD; Jason Gorscak, MD; Priya Mathews, MD Join moderator Ryan G. Smith and fellow YES (and YES emeritus) members Sanja Cypen, Jason…
EyeWorld Weekly, April 26, 2024 – EyeWorld
➤ Topline results for investigational diabetic retinopathy therapy ➤ Dosing complete in second cohort for Phase 1/2 trial for geographic atrophy therapy ➤ Large data…
Clearing up the confusion: get the right anterior chamber depth for ICL – EyeWorld
Among the important indications for use of the EVO ICL (STAAR Surgical)—age, amount of myopia, astigmatism correction, etc.—there is one parameter that some surgeons say…
50 Years | 50 States | 50 Perspectives
In honor of the 50th anniversary of ASCRS, member ophthalmologists from the 50 states are sending in their perspectives on the Society, its impact on…
Physician perspective: Why are cornea specialists failing patients with limbal stem cell deficiency? – EyeWorld
Two physicians detailed Ocular Surface Stem Cell Transplantation with Systemic Immunosuppression for the treatment of severe ocular surface disease with limbal stem cell deficiency and…
Newsletter
ASCRS YES members receive this monthly newsletter that features the latest news, events, and YES-specific opportunities.